What does metastasis-free survival actually mean?

Sweeney, CJ De Abreu Lourenco, R

Hamid, AA Buyse, M

Permalink

Closed Access

	Filename	Description	Size
	rdal_jco_letter.docx	Accepted Manuscript Version	27.32 kB	Microsoft Word XML	View/Open

Copyright Clearance Process

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Sweeney, CJ	en_US
dc.contributor.author	De Abreu Lourenco, R https://orcid.org/0000-0002-5978-8774	en_US
dc.contributor.author	Hamid, AA	en_US
dc.contributor.author	Buyse, M	en_US
dc.date.issued	2019-01-01	en_US
dc.identifier.citation	Journal of Clinical Oncology, 2019, 37 (19), pp. 1679 - 1680	en_US
dc.identifier.issn	0732-183X	en_US
dc.identifier.uri	http://hdl.handle.net/10453/130978
dc.relation.ispartof	Journal of Clinical Oncology	en_US
dc.relation.isbasedon	10.1200/JCO.18.02372	en_US
dc.subject.classification	Oncology & Carcinogenesis	en_US
dc.title	What does metastasis-free survival actually mean?	en_US
dc.type	Journal Article
utslib.citation.volume	19	en_US
utslib.citation.volume	37	en_US
utslib.for	1103 Clinical Sciences	en_US
utslib.for	1112 Oncology and Carcinogenesis	en_US
pubs.embargo.period	Not known	en_US
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Business
pubs.organisational-group	/University of Technology Sydney/Strength - CHERE - Centre for Health Economics Research and Evaluation
utslib.copyright.status	closed_access
pubs.issue	19	en_US
pubs.publication-status	Published	en_US
pubs.volume	37	en_US

Please use this identifier to cite or link to this item: